Abstract:Objectives Serotonin transporter (SERT) can absorb serotonin and may play a key role in irritable bowel syndrome (IBS).The expression of SERT is crucial to the development of IBS and is useful in personalized treatment.The aim of the current study was to create a rat model of post-infectious IBS (PI-IBS) through a decrease in SERT and to facilitate future study of PI-IBS.Methods Sixty adult male SD rats were randomly assigned to one of four groups (n=15 per group):M,A,B,C.Rats were allowed to acclimate for 7 d before treatment.Before inoculation with C.jejuni,all rats were gavaged with 1 ml of 5％ sodium bicarbonate solution to neutralize stomach pH.About 30 min later,the M group were gavaged with 2 ml of sterile saline for 7 d.Group A was gavaged with 108 cfu/ml of C.jejuni (ATCC 2151)for 7 d,group B was gavaged with 109 cfu/ml,and group C was gavaged with 1010 cfu/ml.Biochemical tests and DNA agarose gel electrophoresis were used to assess colonization by C.jejuni.An intestinal infection was detected 3,7,14,28,42,56,and 70 d after infection,and the abdominal withdrawal reflex (AWR) score,the colon transit test,the Bristol stool grade,and levels of SERT mRNA and protein expression were used to evaluate IBS after 70 d.Results During acute infection,bouts of acute infection increased as the concentration of bacteria increased.In the convalescent phase,elimination of water increased significantly in group C.The relative water content of stool was greater in group C after 3 d (P=0.012 for group M,P=0.010 for group A,P=0.027 for group B) and after 7 d (P=0.024 for group M,P=0.031 for group A,P=0.025 for group B).After 42 d,95％ of the rats were no longer infected with C.jejuni.After 56 and 70 d,none of the rats tested positive for C.jejuni.After 70 d,tests were done to evaluate PI-IBS.The AWR score was significantly higher and the colon transit time was briefer for groups B and C (P＜0.05),and especially for group C (vs.M P=0.016;vs.A P=0.042).Moreover,the level of SERT mRNA expression decreased significantly in group C (0.75,0.74,and 0.83 times the level of expression in groups M,A,and B),as did the level of protein expression (0.51,0.80,and 0.76 times the level of expression in groups M,A,and B).Conclusion A high concentration of ATCC 2151 increased the success rate of the model,causing visceral hypersensitivity,disruption of intestin'al motility,and a decrease in SERT expression.

Reduced interstitial cells of Cajal and increased intraepithelial lymphocytes are associated with development of small intestinal bacterial overgrowth in post-infectious IBS mouse model

Small Intestinal Bacterial Overgrowth in Patients with Irritable Bowel Syndrome: Clinical Characteristics, Psychological Factors, and Peripheral Cytokines

Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice

Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis

MLCK-mediated Intestinal Permeability Promotes Immune Activation and Visceral Hypersensitivity in PI-IBS Mice

Altered Intestinal Microbiota with Increased Abundance of Prevotella is Associated with High Risk of Diarrhea-Predominant Irritable Bowel Syndrome.

Aggregation and Self-Assembly of Hydrophobins from Trichoderma Reesei: Low-Resolution Structural Models

Characteristics of Intestinal Lamina Propria Dendritic Cells in a Mouse Model of Postinfectious Irritable Bowel Syndrome

Th1/Th2 shift in gut of mouse model of postinfectious irritable bowel syndrome

Transfer of CD11c+ lamina propria mononuclear phagocytes from post-infectious irritable bowel syndrome causes mucosal barrier dysfunction and visceral hypersensitivity in recipient mice

[Altered Expression of Intestinal Cytokines in Development of Postinfectious Irritable Bowel Syndrome Mouse Model].

Are There Any Different Effects of Bifidobacterium, Lactobacillus and Streptococcus on Intestinal Sensation, Barrier Function and Intestinal Immunity in PI-IBS Mouse Model?

Fecal Microbiota Profiling in Patients with Irritable Bowel Syndrome and Small Intestinal Bacterial Overgrowth

A rat model of PI-IBS with low expression of SERT in the colon as a result of Campylobacter jejuni infection

A Novel Prebiotic Blend Product Prevents Irritable Bowel Syndrome In Mice By Improving Gut Microbiota And Modulating Immune Response

Increased Ileal Immunoglobulin A Production and Immunoglobulin A-Coated Bacteria in Diarrhea-Predominant Irritable Bowel Syndrome

Small intestinal bacterial overgrowth and low-grade systemic inflammation in patients with inflammatory bowel disease

Intestinal Barrier in Post-Campylobacter jejuni Irritable Bowel Syndrome

Duodenal and Rectal Mucosal Microbiota Related to Small Intestinal Bacterial Overgrowth in Diarrhea-Predominant Irritable Bowel Syndrome.

Imbalanced Shift of Cytokine Expression Between T Helper 1 and T Helper 2 (th1/th2) in Intestinal Mucosa of Patients with Post-Infectious Irritable Bowel Syndrome

Transcriptomic and Metabolomic Correlates of Increased Colonic Permeability in Postinfection Irritable Bowel Syndrome